BPC 157 & TB 500: Limitless Biotech Unveils Peptide For Healing & Recovery
December 11, 2024 09:00 ET
|
Limitless Biotech
Gulf Breeze, FL, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leader in cutting-edge biotechnology and health solutions, is excited to announce the release of its groundbreaking peptide...
SBLA Beauty Liquid Facelift Wand Awarded “Serum Product Of The Year” In 2024 Beauty Innovation Awards
November 14, 2024 08:02 ET
|
Beauty Innovation Awards
LOS ANGELES, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The 2024 Beauty Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
Oral Proteins & Peptides Market Research: Semaglutide, Linaclotide, Calcitonin,GLP-1 Receptor Agonist, GEP, CGRP, Diabetes, Gastroenterology, Genetic Disorder - Global Forecast to 2029
November 08, 2024 11:32 ET
|
Research and Markets
Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
October 14, 2024 11:15 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
Peptide Therapeutics Market and Industry Forecast 2024-2032: Total Revenues Forecast to Reach $86.9 Billion by 2032, Dominated by Pfizer, AstraZeneca, Roche, Novo Nordisk and Teva Pharmaceuticals
October 10, 2024 06:34 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032"...
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
October 01, 2024 14:24 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
New Meta-Analysis Shows Treos Bio’s Promiscuous Epitopes in Their Off-The-Shelf Colorectal Cancer Immunotherapy Produce Stronger Immune Response than Traditional Epitopes
September 09, 2024 16:16 ET
|
Treos Bio Corp.
LONDON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Treos Bio announced the results of a meta-analysis from three clinical trials evaluating its investigational off-the-shelf immunotherapy, PolyPEPI1018, for...
Peptide Therapeutics Market Forecast to 2028: Projected to Grow by $17.85 Billion, Driven by a Strong Pipeline and Favorable Reimbursement Policies
August 26, 2024 07:56 ET
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Peptide Therapeutics Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The peptide therapeutics market is forecasted...
Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference
July 16, 2024 07:30 ET
|
Evaxion Biotech
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art...
Global Custom Antibody (mAbs, pAbs, rAbs) Market Research 2024-2030: Service (Development, Purification, Fragmentation, Labeling), Source (Rabbit, Mice), Application (Research, Therapeutics)
June 19, 2024 10:01 ET
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Global Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice),...